CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Vifor Pharma (VIFN) stocks jump 19.08% on takeover talks

By Angela Barnes

11:51, 13 December 2021

View of the Vifor Pharma Group headquarters building in Switzerland
Vifor Pharma stocks jump as takeover talks with CSL confirmed. Photo: Shutterstock.

Vifor Pharma’s stocks went up 19.08% on Monday morning after the Swiss drugmaker and Australia’s CSL confirmed they were talking about a potential merger.

According to Australian media reports, a bid by bio-pharmaceutical giant CSL for Vifor, which specialises in iron supplement and kidney disease treatments, could result in a AUD$10bn (£5.4bn) deal.

“Vifor is in discussions with CSL about a possible transaction. No decisions have been made yet and there is no time frame for this,” Vifor said in a statement to Reuters news agency.

“Until then, Vifor does not comment on these discussions,” it added.

COIN

134.12 Price
+7.790% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.25

NVDA

467.55 Price
+0.310% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.14

GME

15.36 Price
+5.850% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.16

TSLA

239.02 Price
+1.900% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.14

CSL looking to diversify

Australia’s fourth-largest company, CSL, also confirmed the talks to Reuters as it looks to diversify beyond blood plasma products to generate growth.

Capital.com has contacted Vifor and CSL for further comments on the potential merger.

Read more: BHP ends talks for Wyloo support of Noront (NOT) takeover

Related topics

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading